Daewon Pharmaceutical Co., Ltd. (KRX:003220)

South Korea · Delayed Price · Currency is KRW

11,400

-140 (-1.21%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Restrictions	536.09B	500.70B	452.80B	339.08B	306.36B
Restrictions Growth	7.07%	10.58%	33.54%	10.68%	-2.84%
Cosmetics	34.47B	-	-	-	-
Health Functional Food	28.06B	26.48B	25.86B	13.07B	-
Health Functional Food Growth	5.96%	2.39%	97.94%	-	-
Other Sectors	504.20M	-	-	-	-
Consolidated Adjustments	-958.60M	-521.20M	-1.07B	-155.22M	-57.52M
Hearing Aid	-	295.28M	1.29B	2.19B	2.20B
Hearing Aid Growth	-	-77.04%	-41.25%	-0.50%	-24.96%
Total	598.16B	526.95B	478.88B	354.18B	308.50B
Total Growth	13.51%	10.04%	35.21%	14.81%	-2.93%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	566.57B	516.43B	467.17B	343.62B	299.16B
South Korea Growth	9.71%	10.54%	35.96%	14.86%	-3.18%
Overseas	31.59B	10.53B	11.71B	10.56B	9.34B
Overseas Growth	200.16%	-10.15%	10.93%	13.08%	5.50%
Total	598.16B	526.95B	478.88B	354.18B	308.50B
Total Growth	13.51%	10.04%	35.21%	14.81%	-2.93%

Source: S&P Global Market Intelligence.